Furthermore, research has shown that plasma cells displaying the CD138 phenotype are capable of inducing multiple myeloma in SCID-hu mice but fail to generate similar cancers in NOD/SCID mice, highlighting the complexity of modeling multiple myeloma in different immunocompromised mouse strains [75]. This evidence concerns the gene SDC1 and plasma cell myeloma.